• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢综合征患者的手术风险:聚焦于脂质与高血压

Surgical risk in patients with metabolic syndrome: focus on lipids and hypertension.

作者信息

Watson Karol

机构信息

UCLA Cholesterol, Hypertension, and Atherosclerosis Management Program, University of California, Los Angeles Geffen School of Medicine, Los Angeles, CA 90095, USA.

出版信息

Curr Cardiol Rep. 2006 Nov;8(6):433-8. doi: 10.1007/s11886-006-0101-3.

DOI:10.1007/s11886-006-0101-3
PMID:17059795
Abstract

The metabolic syndrome describes a clustering of risk factors that predispose individuals to cardiovascular disease and type 2 diabetes mellitus. Abdominal obesity is a key component of the metabolic syndrome, increasing the incidence of insulin resistance, vascular inflammation, dyslipidemia, and hypertension. Adipose tissue (now recognized as an endocrine organ) and its hormonal products appear to play a significant role in signaling organs throughout the body in the regulation of fat and glucose metabolism. These mechanisms are clearly involved in the development of cardiovascular and metabolic disease and may also lead to increased surgical risks. The components of the syndrome that are most likely to affect surgical patients are obesity, hypertension, and disorders of glucose metabolism. This article focuses on each of these risk factors, the effects on surgical patients, and strategies to improve outcomes in the perioperative period.

摘要

代谢综合征描述了一组使个体易患心血管疾病和2型糖尿病的危险因素聚集。腹部肥胖是代谢综合征的关键组成部分,会增加胰岛素抵抗、血管炎症、血脂异常和高血压的发生率。脂肪组织(现被认为是一个内分泌器官)及其激素产物似乎在调节全身脂肪和葡萄糖代谢的器官信号传导中发挥重要作用。这些机制显然与心血管和代谢疾病的发生有关,也可能导致手术风险增加。该综合征中最有可能影响手术患者的组成部分是肥胖、高血压和葡萄糖代谢紊乱。本文重点关注这些危险因素中的每一个、对手术患者的影响以及改善围手术期结局的策略。

相似文献

1
Surgical risk in patients with metabolic syndrome: focus on lipids and hypertension.代谢综合征患者的手术风险:聚焦于脂质与高血压
Curr Cardiol Rep. 2006 Nov;8(6):433-8. doi: 10.1007/s11886-006-0101-3.
2
Operative risk factors in the metabolic syndrome: is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity?代谢综合征中的手术风险因素:是脂质和高血压,还是胰岛素抵抗及肥胖存在直接血管效应?
Curr Cardiol Rep. 2006 Nov;8(6):427-32. doi: 10.1007/s11886-006-0100-4.
3
Managing cardiometabolic risk: an evolving approach to patient care.管理心脏代谢风险:一种不断发展的患者护理方法。
Crit Pathw Cardiol. 2007 Mar;6(1):5-14. doi: 10.1097/01.hpc.0000255063.43838.6d.
4
Drug treatment of metabolic syndrome.代谢综合征的药物治疗。
Curr Clin Pharmacol. 2013 Aug;8(3):224-31. doi: 10.2174/1574884711308030009.
5
Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity.代谢综合征,一种心血管疾病风险因素:脂肪细胞因子的作用以及饮食和体育活动的影响。
Can J Appl Physiol. 2004 Dec;29(6):808-29. doi: 10.1139/h04-053.
6
The metabolic syndrome: diagnosis and treatment.代谢综合征:诊断与治疗
Clin Cornerstone. 2004;6 Suppl 3:S5-13. doi: 10.1016/s1098-3597(04)80093-0.
7
The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD.代谢综合征与内皮功能障碍:通往2型糖尿病和心血管疾病的共同途径。
Curr Diab Rep. 2006 Aug;6(4):279-86. doi: 10.1007/s11892-006-0061-4.
8
The expanding scope of the metabolic syndrome and implications for the management of cardiovascular risk in type 2 diabetes with particular focus on the emerging role of the thiazolidinediones.代谢综合征范围的扩大及其对2型糖尿病心血管风险管理的影响,尤其关注噻唑烷二酮类药物的新作用。
J Diabetes Complications. 2003 Jul-Aug;17(4):218-28. doi: 10.1016/s1056-8727(03)00002-3.
9
Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes.二甲双胍对腹型肥胖、代谢综合征和2型糖尿病患者心血管疾病风险管理的潜在贡献。
Diabetes Metab. 2003 Sep;29(4 Pt 2):6S53-61. doi: 10.1016/s1262-3636(03)72788-8.
10
Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome.代谢综合征中心血管疾病的病理生理学和治疗学。
Curr Pharm Des. 2013;19(27):4799-805. doi: 10.2174/1381612811319270002.

引用本文的文献

1
Metabolic syndrome increases risk for perioperative outcomes following posterior lumbar interbody fusion.代谢综合征会增加腰椎后路椎间融合术后围手术期不良结局的风险。
Medicine (Baltimore). 2020 Sep 18;99(38):e21786. doi: 10.1097/MD.0000000000021786.
2
Metabolic syndrome and lumbar spine fusion surgery: epidemiology and perioperative outcomes.代谢综合征与腰椎融合手术:流行病学和围手术期结局。
Spine (Phila Pa 1976). 2012 May 15;37(11):989-95. doi: 10.1097/BRS.0b013e31823a3a13.

本文引用的文献

1
Hypertriglyceridemia: management of atherogenic dyslipidemia.高甘油三酯血症:致动脉粥样硬化性血脂异常的管理
J Fam Pract. 2006 Jul;55(7):S1-8.
2
Perioperative glucose control in the diabetic or nondiabetic patient.糖尿病或非糖尿病患者围手术期的血糖控制。
South Med J. 2006 Jun;99(6):580-9; quiz 590-1. doi: 10.1097/01.smj.0000209366.91803.99.
3
ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology.
美国心脏病学会/美国心脏协会2006年非心脏手术围手术期心血管评估指南更新:围手术期β受体阻滞剂治疗重点更新:美国心脏病学会/美国心脏协会实践指南工作组(更新2002年非心脏手术围手术期心血管评估指南写作委员会)报告,与美国超声心动图学会、美国核心脏病学会、心律学会、心血管麻醉医师学会、心血管造影和介入学会以及血管医学与生物学学会合作制定。
J Am Coll Cardiol. 2006 Jun 6;47(11):2343-55. doi: 10.1016/j.jacc.2006.02.028.
4
Hyperglycemia independently increases the risk of perioperative stroke, myocardial infarction, and death after carotid endarterectomy.高血糖会独立增加颈动脉内膜切除术后围手术期中风、心肌梗死和死亡的风险。
Neurosurgery. 2006 Jun;58(6):1066-73; discussion 1066-73. doi: 10.1227/01.NEU.0000215887.59922.36.
5
Cardiac risk reduction in non-cardiac surgery: the role of anaesthesia and monitoring techniques.非心脏手术中降低心脏风险:麻醉与监测技术的作用
Eur J Anaesthesiol. 2006 Aug;23(8):641-8. doi: 10.1017/S0265021506000640. Epub 2006 May 24.
6
Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis.急性胰腺炎早期全身炎症反应、多器官功能障碍严重程度与死亡之间的关联。
Br J Surg. 2006 Jun;93(6):738-44. doi: 10.1002/bjs.5290.
7
Lipid and non-lipid effects of statins.他汀类药物的脂质及非脂质效应。
Handb Exp Pharmacol. 2005(170):365-88. doi: 10.1007/3-540-27661-0_13.
8
Perioperative management of diabetes mellitus: how should we act on the limited evidence?糖尿病的围手术期管理:基于有限证据我们应如何应对?
Cleve Clin J Med. 2006 Mar;73 Suppl 1:S95-9. doi: 10.3949/ccjm.73.suppl_1.s95.
9
Perioperative glucose control.围手术期血糖控制
Curr Opin Anaesthesiol. 2006 Apr;19(2):111-6. doi: 10.1097/01.aco.0000192767.12206.ec.
10
Morbid obesity is an independent determinant of death among surgical critically ill patients.病态肥胖是外科重症患者死亡的独立决定因素。
Crit Care Med. 2006 Apr;34(4):964-70; quiz 971. doi: 10.1097/01.CCM.0000205758.18891.70.